Exclusive: China ramps up checks on U.S. pork imports in potentially costly slowdown
BEIJING (Reuters) – China has ramped up inspections of pork shipped from the United States, importers and industry sources said, the latest American product to be hit by a potentially costly slowdown at Chinese ports in the past couple of weeks.
Germany probes Audi for potential new illegal emissions device
FRANKFURT (Reuters) – German motor vehicle authority KBA has summoned Audi for a formal hearing about whether its diesel-engined A6/A7 models have been fitted with a previously unknown defeat device, Germany’s Transport Ministry said on Tuesday.
European regulators: We’re not ready for new privacy law
FRANKFURT/BRUSSELS/PARIS (Reuters) – Europe’s General Data Protection Regulation (GDPR) has been billed as the biggest shake-up of data privacy laws since the birth of the web.
Tech sector gains keep world shares near one-week high
LONDON (Reuters) – Oil prices eased on Tuesday from 3-1/2-year highs they hit on worries the United States may be set to pull out of a key nuclear accord with Iran, but robust tech sector gains in Asia helped support world stocks near one-week highs.
Elliott backing request to appoint special auditor: Uniper CEO
FRANKFURT (Reuters) – Uniper said a motion to appoint a special auditor at this year’s annual general meeting to identify possible breaches of duty and violations of the law by the group’s management is backed by shareholder Elliott.
New Volkswagen CEO testified in U.S. on emissions scandal: report
BERLIN (Reuters) – Volkswagen Chief Executive Herbert Diess traveled to the United States this month to testify to authorities there about the carmaker’s emissions scandal, German newspaper Bild reported on Tuesday.
Japan’s Takeda clinches $62 billion deal to buy drugmaker Shire
LONDON/TOKYO (Reuters) – Takeda Pharmaceutical agreed to buy London-listed Shire for 45.3 billion pounds ($61.50 billion) on Tuesday, marking the biggest deal yet in a wave of transactions sweeping the drugs industry.
Japan’s Takeda agrees $62 billion takeover of Shire
LONDON (Reuters) – Takeda Pharmaceutical agreed to buy London-listed Shire for 45.3 billion pounds ($61.50 billion) on Tuesday after the Japanese company raised the amount of cash in its offer to $30.33 to secure a recommendation.
Oil hovers near 3 1/2-year peak, Asia shares up ahead of Trump announcement
TOKYO/SHANGHAI (Reuters) – Oil prices eased slightly on Tuesday, a day after hitting 3-1/2 year highs, as investors braced for President Donald Trump’s decision on whether to withdraw the United States from the Iran nuclear deal, a move that could disr…
Japan’s Takeda agrees to $62 billion takeover of Shire
LONDON (Reuters) – Takeda Pharma agreed to buy London-listed Shire for 46 billion pounds ($62.42 billion) on Tuesday after the Japanese company raised the amount of cash in its offer to $30.33 to secure a recommendation.
